학술논문
ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer
Document Type
Practice Guideline
Author
Source
In Annals of Oncology December 2020 31(12):1606-1622
Subject
Language
ISSN
0923-7534